APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fourth Generation Fluoroquinolones

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Fourth Generation Fluoroquinolones Industry Growth and Trends Forecast to 2032

26 December 202590 pages

Choose your research edition.

Industry ResearchFourth Generation Fluoroquinolones Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Fourth Generation Fluoroquinolones Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Fourth Generation Fluoroquinolones Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fourth Generation Fluoroquinolones Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Fourth Generation Fluoroquinolones Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Fourth Generation Fluoroquinolones market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fourth Generation Fluoroquinolones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fourth Generation Fluoroquinolones include Takeda, Sanofi, Nanjing Youke Pharmaceutical, Pfizer, Daiichi Sankyo Co., Ltd., Otsuka Holdings, Bayer AG and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Fourth Generation Fluoroquinolones market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Fourth Generation Fluoroquinolones market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fourth Generation Fluoroquinolones market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fourth Generation Fluoroquinolones.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Fourth Generation Fluoroquinolones market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Fourth Generation Fluoroquinolones Market by Company

Takeda

Sanofi

Nanjing Youke Pharmaceutical

Pfizer

Daiichi Sankyo Co., Ltd.

Otsuka Holdings

Bayer AG

Astellas

Fourth Generation Fluoroquinolones Segment by Type

Besifloxacin

Delafloxacin

Jimmyfloxacin

Gatifloxacin

Moxifloxacin

Prulifloxacin

Sitafloxacin

Others

Fourth Generation Fluoroquinolones Segment by Application

Skin And Soft Tissue Infections

Urinary Tract Disease

Respiratory Diseases

Bone, Joint, And Soft Tissue Infections

Intestinal Infections And Typhoid Fever

Others

Fourth Generation Fluoroquinolones Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fourth Generation Fluoroquinolones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fourth Generation Fluoroquinolones and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fourth Generation Fluoroquinolones.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fourth Generation Fluoroquinolones manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Fourth Generation Fluoroquinolones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Besifloxacin Table 2. Major Company of Delafloxacin Table 3. Major Company of Jimmyfloxacin Table 4. Major Company of Gatifloxacin Table 5. Major Company of Moxifloxacin Table 6. Major Company of Prulifloxacin Table 7. Major Company of Sitafloxacin Table 8. Major Company of Others Table 9. Global Fourth Generation Fluoroquinolones Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (K Units) Table 11. Global Fourth Generation Fluoroquinolones Sales Market Share in Volume by Type (2021-2026) Table 12. Global Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (US$ Million) Table 13. Global Fourth Generation Fluoroquinolones Sales Market Share in Value by Type (2021-2026) Table 14. Global Fourth Generation Fluoroquinolones Price by Type (2021-2026) & (US$/K Unit) Table 15. Global Fourth Generation Fluoroquinolones Sales by Type (2027-2032) & (K Units) Table 16. Global Fourth Generation Fluoroquinolones Sales Market Share in Volume by Type (2027-2032) Table 17. Global Fourth Generation Fluoroquinolones Sales by Type (2027-2032) & (US$ Million) Table 18. Global Fourth Generation Fluoroquinolones Sales Market Share in Value by Type (2027-2032) Table 19. Global Fourth Generation Fluoroquinolones Price by Type (2027-2032) & (US$/K Unit) Table 20. North America Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (K Units) Table 21. North America Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (US$ Million) Table 22. Europe Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (K Units) Table 23. Europe Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (K Units) Table 25. Asia-Pacific Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (K Units) Table 27. Latin America Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (K Units) Table 29. Middle East and Africa Fourth Generation Fluoroquinolones Sales by Type (2021-2026) & (US$ Million) Table 30. Fourth Generation Fluoroquinolones Industry Trends Table 31. Fourth Generation Fluoroquinolones Industry Drivers Table 32. Fourth Generation Fluoroquinolones Industry Opportunities and Challenges Table 33. Fourth Generation Fluoroquinolones Industry Restraints Table 34. Global Fourth Generation Fluoroquinolones Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global Fourth Generation Fluoroquinolones Revenue Market Share by Company (2021-2026) Table 36. Global Fourth Generation Fluoroquinolones Sales by Company (2021-2026) & (K Units) Table 37. Global Fourth Generation Fluoroquinolones Sales Share by Company (2021-2026) Table 38. Global Fourth Generation Fluoroquinolones Market Price by Company (2021-2026) & (US$/K Unit) Table 39. Global Fourth Generation Fluoroquinolones Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global Fourth Generation Fluoroquinolones Major Company Production Sites and Headquarters Table 41. Global Fourth Generation Fluoroquinolones Company, Product Type & Application Table 42. Global Fourth Generation Fluoroquinolones Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global Fourth Generation Fluoroquinolones by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global Fourth Generation Fluoroquinolones Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global Fourth Generation Fluoroquinolones Sales by Region (2021-2026) & (K Units) Table 47. Global Fourth Generation Fluoroquinolones Sales Market Share in Volume by Region (2021-2026) Table 48. Global Fourth Generation Fluoroquinolones Sales by Region (2021-2026) & (US$ Million) Table 49. Global Fourth Generation Fluoroquinolones Sales Market Share in Value by Region (2021-2026) Table 50. Global Fourth Generation Fluoroquinolones Sales (K Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 51. Global Fourth Generation Fluoroquinolones Sales by Region (2027-2032) & (K Units) Table 52. Global Fourth Generation Fluoroquinolones Sales Market Share in Volume by Region (2027-2032) Table 53. Global Fourth Generation Fluoroquinolones Sales by Region (2027-2032) & (US$ Million) Table 54. Global Fourth Generation Fluoroquinolones Sales Market Share in Value by Region (2027-2032) Table 55. Global Fourth Generation Fluoroquinolones Sales (K Units), Value (US$ Million), Price (US$/K Unit) and Gross Margin (2027-2032) Table 56. Global Fourth Generation Fluoroquinolones Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (K Units) Table 58. Global Fourth Generation Fluoroquinolones Sales Market Share in Volume by Application (2021-2026) Table 59. Global Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (US$ Million) Table 60. Global Fourth Generation Fluoroquinolones Sales Market Share in Value by Application (2021-2026) Table 61. Global Fourth Generation Fluoroquinolones Price by Application (2021-2026) & (US$/K Unit) Table 62. Global Fourth Generation Fluoroquinolones Sales by Application (2027-2032) & (K Units) Table 63. Global Fourth Generation Fluoroquinolones Sales Market Share in Volume by Application (2027-2032) Table 64. Global Fourth Generation Fluoroquinolones Sales by Application (2027-2032) & (US$ Million) Table 65. Global Fourth Generation Fluoroquinolones Sales Market Share in Value by Application (2027-2032) Table 66. Global Fourth Generation Fluoroquinolones Price by Application (2027-2032) & (US$/K Unit) Table 67. North America Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (K Units) Table 68. North America Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (US$ Million) Table 69. Europe Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (K Units) Table 70. Europe Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (K Units) Table 72. Asia-Pacific Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (K Units) Table 74. Latin America Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (K Units) Table 76. Middle East and Africa Fourth Generation Fluoroquinolones Sales by Application (2021-2026) & (US$ Million) Table 77. Takeda Company Information Table 78. Takeda Business Overview Table 79. Takeda Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 80. Takeda Fourth Generation Fluoroquinolones Product Portfolio Table 81. Takeda Recent Development Table 82. Sanofi Company Information Table 83. Sanofi Business Overview Table 84. Sanofi Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 85. Sanofi Fourth Generation Fluoroquinolones Product Portfolio Table 86. Sanofi Recent Development Table 87. Nanjing Youke Pharmaceutical Company Information Table 88. Nanjing Youke Pharmaceutical Business Overview Table 89. Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 90. Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Product Portfolio Table 91. Nanjing Youke Pharmaceutical Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 95. Pfizer Fourth Generation Fluoroquinolones Product Portfolio Table 96. Pfizer Recent Development Table 97. Daiichi Sankyo Co., Ltd. Company Information Table 98. Daiichi Sankyo Co., Ltd. Business Overview Table 99. Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 100. Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Product Portfolio Table 101. Daiichi Sankyo Co., Ltd. Recent Development Table 102. Otsuka Holdings Company Information Table 103. Otsuka Holdings Business Overview Table 104. Otsuka Holdings Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 105. Otsuka Holdings Fourth Generation Fluoroquinolones Product Portfolio Table 106. Otsuka Holdings Recent Development Table 107. Bayer AG Company Information Table 108. Bayer AG Business Overview Table 109. Bayer AG Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 110. Bayer AG Fourth Generation Fluoroquinolones Product Portfolio Table 111. Bayer AG Recent Development Table 112. Astellas Company Information Table 113. Astellas Business Overview Table 114. Astellas Fourth Generation Fluoroquinolones Sales (K Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2021-2026) Table 115. Astellas Fourth Generation Fluoroquinolones Product Portfolio Table 116. Astellas Recent Development Table 117. North America Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 119. North America Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2026) Table 120. North America Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Fourth Generation Fluoroquinolones Sales Market Share Forecast by Country (2027-2032) Table 122. North America Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Fourth Generation Fluoroquinolones Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Fourth Generation Fluoroquinolones Market Share by Country (2021-2026) Table 125. North America Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Fourth Generation Fluoroquinolones Market Share Forecast by Country (2027-2032) Table 127. Europe Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 129. Europe Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2026) Table 130. Europe Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Fourth Generation Fluoroquinolones Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Fourth Generation Fluoroquinolones Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Fourth Generation Fluoroquinolones Market Share by Country (2021-2026) Table 135. Europe Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Fourth Generation Fluoroquinolones Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Fourth Generation Fluoroquinolones Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Fourth Generation Fluoroquinolones Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Fourth Generation Fluoroquinolones Market Share by Country (2021-2026) Table 145. Asia-Pacific Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Fourth Generation Fluoroquinolones Market Share Forecast by Country (2027-2032) Table 147. Latin America Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 149. Latin America Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2026) Table 150. Latin America Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Fourth Generation Fluoroquinolones Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Fourth Generation Fluoroquinolones Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Fourth Generation Fluoroquinolones Market Share by Country (2021-2026) Table 155. Latin America Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Fourth Generation Fluoroquinolones Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Fourth Generation Fluoroquinolones Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Fourth Generation Fluoroquinolones Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Fourth Generation Fluoroquinolones Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Fourth Generation Fluoroquinolones Market Share by Country (2021-2026) Table 165. Middle East and Africa Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Fourth Generation Fluoroquinolones Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Fourth Generation Fluoroquinolones Distributors List Table 170. Fourth Generation Fluoroquinolones Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Fourth Generation Fluoroquinolones Image Figure 2. Global Fourth Generation Fluoroquinolones Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fourth Generation Fluoroquinolones Market Size (2021-2032) & (US$ Million) Figure 4. Global Fourth Generation Fluoroquinolones Sales (2021-2032) & (K Units) Figure 5. Besifloxacin Image Figure 6. Global Besifloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Delafloxacin Image Figure 8. Global Delafloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Jimmyfloxacin Image Figure 10. Global Jimmyfloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Gatifloxacin Image Figure 12. Global Gatifloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 13. Moxifloxacin Image Figure 14. Global Moxifloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 15. Prulifloxacin Image Figure 16. Global Prulifloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 17. Sitafloxacin Image Figure 18. Global Sitafloxacin Sales YoY Growth (2021-2032) & (K Units) Figure 19. Others Image Figure 20. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 21. Global Fourth Generation Fluoroquinolones Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global Fourth Generation Fluoroquinolones Market Share by Type 2025 VS 2032 Figure 23. North America Fourth Generation Fluoroquinolones Sales Market Share in Volume by Type in 2025 Figure 24. North America Fourth Generation Fluoroquinolones Sales Market Share in Value by Type in 2025 Figure 25. Europe Fourth Generation Fluoroquinolones Sales Market Share in Volume by Type in 2025 Figure 26. Europe Fourth Generation Fluoroquinolones Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific Fourth Generation Fluoroquinolones Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific Fourth Generation Fluoroquinolones Sales Market Share in Value by Type in 2025 Figure 29. Latin America Fourth Generation Fluoroquinolones Sales Market Share in Volume by Type in 2025 Figure 30. Latin America Fourth Generation Fluoroquinolones Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa Fourth Generation Fluoroquinolones Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa Fourth Generation Fluoroquinolones Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 Fourth Generation Fluoroquinolones Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Skin And Soft Tissue Infections Image Figure 36. Global Skin And Soft Tissue Infections Sales YoY Growth (2021-2032) & (K Units) Figure 37. Urinary Tract Disease Image Figure 38. Global Urinary Tract Disease Sales YoY Growth (2021-2032) & (K Units) Figure 39. Respiratory Diseases Image Figure 40. Global Respiratory Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 41. Bone, Joint, And Soft Tissue Infections Image Figure 42. Global Bone, Joint, And Soft Tissue Infections Sales YoY Growth (2021-2032) & (K Units) Figure 43. Intestinal Infections And Typhoid Fever Image Figure 44. Global Intestinal Infections And Typhoid Fever Sales YoY Growth (2021-2032) & (K Units) Figure 45. Others Image Figure 46. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 47. Global Fourth Generation Fluoroquinolones Market Size Overview by Application (2021-2032) & (US$ Million) Figure 48. Global Fourth Generation Fluoroquinolones Market Share by Application 2025 VS 2032 Figure 49. North America Fourth Generation Fluoroquinolones Sales Market Share in Volume by Application in 2025 Figure 50. North America Fourth Generation Fluoroquinolones Sales Market Share in Value by Application in 2025 Figure 51. Europe Fourth Generation Fluoroquinolones Sales Market Share in Volume by Application in 2025 Figure 52. Europe Fourth Generation Fluoroquinolones Sales Market Share in Value by Application in 2025 Figure 53. Asia-Pacific Fourth Generation Fluoroquinolones Sales Market Share in Volume by Application in 2025 Figure 54. Asia-Pacific Fourth Generation Fluoroquinolones Sales Market Share in Value by Application in 2025 Figure 55. Latin America Fourth Generation Fluoroquinolones Sales Market Share in Volume by Application in 2025 Figure 56. Latin America Fourth Generation Fluoroquinolones Sales Market Share in Value by Application in 2025 Figure 57. Middle East and Africa Fourth Generation Fluoroquinolones Sales Market Share in Volume by Application in 2025 Figure 58. Middle East and Africa Fourth Generation Fluoroquinolones Sales Market Share in Value by Application in 2025 Figure 59. North America Fourth Generation Fluoroquinolones Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. North America Fourth Generation Fluoroquinolones Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. North America Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. North America Fourth Generation Fluoroquinolones Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Fourth Generation Fluoroquinolones Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Europe Fourth Generation Fluoroquinolones Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Europe Fourth Generation Fluoroquinolones Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Fourth Generation Fluoroquinolones Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Asia-Pacific Fourth Generation Fluoroquinolones Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Asia-Pacific Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Asia-Pacific Fourth Generation Fluoroquinolones Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Latin America Fourth Generation Fluoroquinolones Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Latin America Fourth Generation Fluoroquinolones Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Latin America Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Latin America Fourth Generation Fluoroquinolones Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 76. Middle East and Africa Fourth Generation Fluoroquinolones Sales Share by Country: 2021 VS 2025 VS 2032 Figure 77. Middle East and Africa Fourth Generation Fluoroquinolones Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 78. Middle East and Africa Fourth Generation Fluoroquinolones Market Share by Country: 2021 VS 2025 VS 2032 Figure 79. Fourth Generation Fluoroquinolones Value Chain Figure 80. Key Raw Materials Price Figure 81. Manufacturing Cost Structure Figure 82. Fourth Generation Fluoroquinolones Production Mode & Process Figure 83. Direct Comparison with Distribution Share Figure 84. Distributors Profiles Figure 85. Years Considered Figure 86. Research Process Figure 87. Key Executives Interviewed

Scope & coverage.

Types
  • Besifloxacin
  • Delafloxacin
  • Jimmyfloxacin
  • Gatifloxacin
  • Moxifloxacin
  • Prulifloxacin
  • Sitafloxacin
  • Others
Applications
  • Skin And Soft Tissue Infections
  • Urinary Tract Disease
  • Respiratory Diseases
  • Bone, Joint, And Soft Tissue Infections
  • Intestinal Infections And Typhoid Fever
  • Others
Companies covered
  • Takeda
  • Sanofi
  • Nanjing Youke Pharmaceutical
  • Pfizer
  • Daiichi Sankyo Co., Ltd.
  • Otsuka Holdings
  • Bayer AG
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fourth Generation Fluoroquinolones Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Fourth Generation Fluoroquinolones Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Fourth Generation Fluoroquinolones Market by Type
  6. 1.3.1 Besifloxacin
  7. 1.3.2 Delafloxacin
  8. 1.3.3 Jimmyfloxacin
  9. 1.3.4 Gatifloxacin
  10. 1.3.5 Moxifloxacin
  11. 1.3.6 Prulifloxacin
  12. 1.3.7 Sitafloxacin
  13. 1.3.8 Others
  14. 1.4 Global Fourth Generation Fluoroquinolones Market Size by Type
  15. 1.4.1 Global Fourth Generation Fluoroquinolones Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global Fourth Generation Fluoroquinolones Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global Fourth Generation Fluoroquinolones Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America Fourth Generation Fluoroquinolones Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe Fourth Generation Fluoroquinolones Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific Fourth Generation Fluoroquinolones Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America Fourth Generation Fluoroquinolones Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa Fourth Generation Fluoroquinolones Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Fourth Generation Fluoroquinolones Industry Trends
  2. 2.2 Fourth Generation Fluoroquinolones Industry Drivers
  3. 2.3 Fourth Generation Fluoroquinolones Industry Opportunities and Challenges
  4. 2.4 Fourth Generation Fluoroquinolones Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Fourth Generation Fluoroquinolones Revenue (2021-2026)
  2. 3.2 Global Top Players by Fourth Generation Fluoroquinolones Sales (2021-2026)
  3. 3.3 Global Top Players by Fourth Generation Fluoroquinolones Price (2021-2026)
  4. 3.4 Global Fourth Generation Fluoroquinolones Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fourth Generation Fluoroquinolones Major Company Production Sites & Headquarters
  6. 3.6 Global Fourth Generation Fluoroquinolones Company, Product Type & Application
  7. 3.7 Global Fourth Generation Fluoroquinolones Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fourth Generation Fluoroquinolones Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fourth Generation Fluoroquinolones Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fourth Generation Fluoroquinolones Tier 1, Tier 2, and Tier 3
4 Fourth Generation Fluoroquinolones Regional Status and Outlook
  1. 4.1 Global Fourth Generation Fluoroquinolones Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Fourth Generation Fluoroquinolones Historic Market Size by Region
  3. 4.2.1 Global Fourth Generation Fluoroquinolones Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Fourth Generation Fluoroquinolones Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Fourth Generation Fluoroquinolones Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Fourth Generation Fluoroquinolones Forecasted Market Size by Region
  7. 4.3.1 Global Fourth Generation Fluoroquinolones Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Fourth Generation Fluoroquinolones Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Fourth Generation Fluoroquinolones Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fourth Generation Fluoroquinolones by Application
  1. 5.1 Fourth Generation Fluoroquinolones Market by Application
  2. 5.1.1 Skin And Soft Tissue Infections
  3. 5.1.2 Urinary Tract Disease
  4. 5.1.3 Respiratory Diseases
  5. 5.1.4 Bone, Joint, And Soft Tissue Infections
  6. 5.1.5 Intestinal Infections And Typhoid Fever
  7. 5.1.6 Others
  8. 5.2 Global Fourth Generation Fluoroquinolones Market Size by Application
  9. 5.2.1 Global Fourth Generation Fluoroquinolones Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Fourth Generation Fluoroquinolones Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Fourth Generation Fluoroquinolones Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Fourth Generation Fluoroquinolones Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Fourth Generation Fluoroquinolones Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Fourth Generation Fluoroquinolones Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Fourth Generation Fluoroquinolones Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Fourth Generation Fluoroquinolones Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Fourth Generation Fluoroquinolones Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Fourth Generation Fluoroquinolones Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Nanjing Youke Pharmaceutical
  14. 6.3.1 Nanjing Youke Pharmaceutical Company Information
  15. 6.3.2 Nanjing Youke Pharmaceutical Business Overview
  16. 6.3.3 Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nanjing Youke Pharmaceutical Fourth Generation Fluoroquinolones Product Portfolio
  18. 6.3.5 Nanjing Youke Pharmaceutical Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Fourth Generation Fluoroquinolones Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Daiichi Sankyo Co., Ltd.
  26. 6.5.1 Daiichi Sankyo Co., Ltd. Company Information
  27. 6.5.2 Daiichi Sankyo Co., Ltd. Business Overview
  28. 6.5.3 Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Daiichi Sankyo Co., Ltd. Fourth Generation Fluoroquinolones Product Portfolio
  30. 6.5.5 Daiichi Sankyo Co., Ltd. Recent Developments
  31. 6.6 Otsuka Holdings
  32. 6.6.1 Otsuka Holdings Company Information
  33. 6.6.2 Otsuka Holdings Business Overview
  34. 6.6.3 Otsuka Holdings Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Otsuka Holdings Fourth Generation Fluoroquinolones Product Portfolio
  36. 6.6.5 Otsuka Holdings Recent Developments
  37. 6.7 Bayer AG
  38. 6.7.1 Bayer AG Company Information
  39. 6.7.2 Bayer AG Business Overview
  40. 6.7.3 Bayer AG Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer AG Fourth Generation Fluoroquinolones Product Portfolio
  42. 6.7.5 Bayer AG Recent Developments
  43. 6.8 Astellas
  44. 6.8.1 Astellas Company Information
  45. 6.8.2 Astellas Business Overview
  46. 6.8.3 Astellas Fourth Generation Fluoroquinolones Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Astellas Fourth Generation Fluoroquinolones Product Portfolio
  48. 6.8.5 Astellas Recent Developments
7 North America by Country
  1. 7.1 North America Fourth Generation Fluoroquinolones Sales by Country
  2. 7.1.1 North America Fourth Generation Fluoroquinolones Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Fourth Generation Fluoroquinolones Sales by Country (2021-2026)
  4. 7.1.3 North America Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032)
  5. 7.2 North America Fourth Generation Fluoroquinolones Market Size by Country
  6. 7.2.1 North America Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Fourth Generation Fluoroquinolones Market Size by Country (2021-2026)
  8. 7.2.3 North America Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Fourth Generation Fluoroquinolones Sales by Country
  2. 8.1.1 Europe Fourth Generation Fluoroquinolones Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Fourth Generation Fluoroquinolones Sales by Country (2021-2026)
  4. 8.1.3 Europe Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Fourth Generation Fluoroquinolones Market Size by Country
  6. 8.2.1 Europe Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Fourth Generation Fluoroquinolones Market Size by Country (2021-2026)
  8. 8.2.3 Europe Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Fourth Generation Fluoroquinolones Sales by Country
  2. 9.1.1 Asia-Pacific Fourth Generation Fluoroquinolones Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Fourth Generation Fluoroquinolones Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Fourth Generation Fluoroquinolones Market Size by Country
  6. 9.2.1 Asia-Pacific Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Fourth Generation Fluoroquinolones Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Fourth Generation Fluoroquinolones Sales by Country
  2. 10.1.1 South America Fourth Generation Fluoroquinolones Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Fourth Generation Fluoroquinolones Sales by Country (2021-2026)
  4. 10.1.3 South America Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032)
  5. 10.2 South America Fourth Generation Fluoroquinolones Market Size by Country
  6. 10.2.1 South America Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Fourth Generation Fluoroquinolones Market Size by Country (2021-2026)
  8. 10.2.3 South America Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country
  2. 11.1.1 Middle East and Africa Fourth Generation Fluoroquinolones Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Fourth Generation Fluoroquinolones Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Fourth Generation Fluoroquinolones Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Fourth Generation Fluoroquinolones Market Size by Country
  6. 11.2.1 Middle East and Africa Fourth Generation Fluoroquinolones Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Fourth Generation Fluoroquinolones Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Fourth Generation Fluoroquinolones Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Fourth Generation Fluoroquinolones Value Chain Analysis
  2. 12.1.1 Fourth Generation Fluoroquinolones Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Fourth Generation Fluoroquinolones Production Mode & Process
  7. 12.2 Fourth Generation Fluoroquinolones Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Fourth Generation Fluoroquinolones Distributors
  10. 12.2.3 Fourth Generation Fluoroquinolones Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst